Literature DB >> 9537153

Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site.

H Kiratli1, C E Thirkill, S Bilgiç, B Eldem, A Keçeci.   

Abstract

PURPOSE: To describe further the clinical and immunological features of cutaneous melanoma-associated retinopathy, which is an infrequent form of paraneoplastic syndrome.
METHODS: We studied the salient clinical and immunological aspects of a 66-year-old man with metastatic cutaneous melanoma to lymph nodes of unknown primary site who developed melanoma-associated retinopathy.
RESULTS: There was gradual loss of vision in the left eye. Colour vision and night vision were not affected. Visual fields showed arcuate defects. A full-field electroretinogram demonstrated attenuation of the b-wave amplitude in the left eye. The a-wave was intact. Indirect immunofluorescence techniques showed that the antibody reactions took place mainly in the outer plexiform layer of the retina.
CONCLUSIONS: Bipolar cells seem to be the target in melanoma-associated retinopathy. Contrary to previous reports, night blindness may not be a universal finding.

Entities:  

Mesh:

Year:  1997        PMID: 9537153     DOI: 10.1038/eye.1997.227

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  7 in total

1.  Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.

Authors:  R Peek; B G Dijkstra; B Meek; R W A M Kuijpers
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

2.  Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach.

Authors:  Monica D Dalal; Catherine W Morgans; Robert M Duvoisin; Elizabeth A Gamboa; Brett G Jeffrey; Sunir J Garg; Chi-Chao Chan; H Nida Sen
Journal:  Ophthalmology       Date:  2013-09-17       Impact factor: 12.079

3.  Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.

Authors:  Richard E Stead; Maryke A Fox; Emily Staples; Chea S Lim
Journal:  Doc Ophthalmol       Date:  2013-06-22       Impact factor: 2.379

4.  Presumed melanoma-associated retinopathy (MAR): a presenting sign of primary small intestinal melanoma?

Authors:  Daniel Rappoport; Hana Leiba
Journal:  Int Ophthalmol       Date:  2012-04-24       Impact factor: 2.031

Review 5.  Autoimmune retinopathy: a review and summary.

Authors:  John R Heckenlively; Henry A Ferreyra
Journal:  Semin Immunopathol       Date:  2008-04-12       Impact factor: 9.623

6.  Paraneoplastic Retinopathy/Optic Neuropathy.

Authors:  Denise M Damek
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

7.  A three-year longitudinal study of retinal function and structure in patients with multiple sclerosis.

Authors:  James V M Hanson; Mei-Yee Ng; Helen K Hayward-Koennecke; Sven Schippling; Kelly A Reeve; Christina Gerth-Kahlert
Journal:  Doc Ophthalmol       Date:  2021-10-27       Impact factor: 2.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.